flecainide has been researched along with Myoclonic Jerk in 2 studies
Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 73 year-old patient with Wolff-Parkinson-White syndrome and paroxysmic supraventricular tachycardia developed an acute reversible encephalopathy within 15 days of initiation of flecainide." | 3.69 | Acute reversible ataxo-myoclonic encephalopathy with flecainide therapy. ( Ghika, J; Goy, JJ; Naegeli, C; Regli, F, 1994) |
| "Flecainide is a sodium channel blocker used mainly in the treatment of supraventricular arrhythmias." | 1.35 | Paranoid psychosis and myoclonus: flecainide toxicity in renal failure. ( Lee, D; Maclean, D; Sheerin, NS; Ting, SM, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ting, SM | 1 |
| Lee, D | 1 |
| Maclean, D | 1 |
| Sheerin, NS | 1 |
| Ghika, J | 1 |
| Goy, JJ | 1 |
| Naegeli, C | 1 |
| Regli, F | 1 |
2 other studies available for flecainide and Myoclonic Jerk
| Article | Year |
|---|---|
Paranoid psychosis and myoclonus: flecainide toxicity in renal failure.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Diabetes Mellitus, Type 2; Dose-Response Relationship, | 2008 |
Acute reversible ataxo-myoclonic encephalopathy with flecainide therapy.
Topics: Aged; Cerebellar Ataxia; Drug Interactions; Drug Therapy, Combination; Flecainide; Humans; Male; Myo | 1994 |